Cardiogenesis Corporation (OTC:CGCP) will release the fourth quarter earnings for 2007 on March 4.
Cardiogenesis is involved in the design, development and
distribution of laser based surgical products and disposable fiber-optic
accessories to treat ischemia related to advanced cardiovascular disease through
transmyocardial revascularization (TMR) and percutaneious myocardial channeling
(PMC). Port enabled angina relief using
laser (
For more Earnings related events or to post your own events, visit: